Astorg and Amulet Capital Partners today announced that the previously disclosed acquisition of OPEN Health by Astorg, a top global provider of scientific communications and market access services to the pharmaceutical sector, had been completed. OPEN Health, which was founded in 2011 and has more than 1,000 employees across 15 […]
Featured News
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
Twist Bioscience Corporation, a business that helps clients succeed by providing high-quality synthetic DNA utilising its silicon platform, has introduced two synthetic DNA controllers for the human monkeypox virus. Positive controls offer quality assurance checks for the creation, confirmation, and continuous validation of both polymerase chain reaction (PCR) and next-generation […]
Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare
Global public and private expenditure on healthcare exceeded USD10 trillion in 2021, making the industry one of the most important globally. Yet, the inflationary environment is threatening this development. While some of the major health trends, like shifting to healthier behaviours or adopting telehealth, are clearly benefiting from the search […]
Discovery Life Sciences Acquires AllCells
Discovery Life Sciences, the biospecimen and biomarker specialists, today announced its acquisition of AllCells®, a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will focus on providing revolutionary products […]
Adventist Health Selects Emcara Health to Address the Needs of Medi-Cal’s Most Vulnerable Members
Emcara Health, a national value-based medical group for PopHealthCare, today announced a partnership with Adventist Health of California to expand treatment into high-risk areas all over the state. Emcara Health provides sophisticated in-home primary care for elders and vulnerable populations. The alliance, which is a part of CalAIM’s larger Enhanced […]
AHF warns WHO that monkeypox is a pandemic
The AIDS Healthcare Foundation (AHF) implores the World Health Organization to swiftly declare the monkeypox outbreak a Public Health Emergency of International Concern and avoid making the same mistakes as in the past by delaying announcements regarding COVID-19 with more than 7,600 cases in 58 countries (USPPI). The WHO took […]
EarlySign Announces Collaboration with Roche on AI Solution for Early Detection of Lung Cancer
Medial EarlySign, a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today the signing of a new partnership with Roche, which will focus on innovative, evidence-based solutions for early detection of lung cancer. In 2020, over 235,000 people in the US and over 2.2 million people worldwide […]
FDA permits pharmacists to prescribe Paxlovid to treat COVID-19
After months of effort by the American Pharmacists Association (APhA) and other stakeholders, FDA has updated the EUA for the COVID-19 oral antiviral, Paxlovid, to permit pharmacists to order and prescribe Paxlovid under certain conditions. The federal government had already authorized pharmacists to order and dispense oral therapeutics under the PREP Act. However, the ability for […]
Catharina Hospital Selects HPE Ezmeral to Power Data-First Modernization and Improve Accuracy and Speed of Diagnosis
Hewlett Packard Enterprise today announced that Catharina Hospital, the largest hospital in the Netherlands’ Eindhoven region, providing care for over 150,000 patients, has selected the HPE Ezmeral software portfolio to build a cloud-native analytics and data lakehouse to provide more accurate diagnosis, early detection and injury prevention for patients. Every […]
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
The collaboration combines Aurigene’s small molecule drug discovery platform and EQRx’s pioneering business model to accelerate the development of drug candidates in the areas of oncology and immune-inflammatory diseases and improve global access to innovative medicines. Under the terms of the collaboration agreement, Aurigene and EQRx will collaborate on drug […]
